The investment seeks a high level of current income; capital appreciation is the secondary objective... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ModerateAllocation
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ILCG | 117.14 | 2.24 | +1.95% |
| iShares Morningstar Growth ETF | |||
| DUNK | 24.48 | 0.31 | +1.28% |
| Dana Unconstrained Equity ETF | |||
| AIVL | 128.88 | 1.05 | +0.82% |
| WisdomTree US Al Enhanced Val ETF | |||
| ZOCT | 27.59 | 0.04 | +0.15% |
| Innovator Eq Dfnd Prt ETF - 1 Yr Oct | |||
| BIB | 85.02 | 0.07 | +0.08% |
| ProShares Ultra Nasdaq Biotechnology | |||
A.I.dvisor indicates that over the last year, FCANX has been closely correlated with BCICX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if FCANX jumps, then BCICX could also see price increases.
| Ticker / NAME | Correlation To FCANX | 1D Price Change % | ||
|---|---|---|---|---|
| FCANX | 100% | +0.61% | ||
| BCICX - FCANX | 93% Closely correlated | +0.38% | ||
| BIICX - FCANX | 92% Closely correlated | +0.28% | ||
| BKMIX - FCANX | 92% Closely correlated | +0.38% | ||
| BAICX - FCANX | 92% Closely correlated | +0.38% | ||
| HBLCX - FCANX | 86% Closely correlated | +0.07% | ||
More | ||||